コンテンツへスキップ
Merck
  • Physical characterization of drug:polymer dispersion behavior in polyethylene glycol 4000 solid dispersions using a suite of complementary analytical techniques.

Physical characterization of drug:polymer dispersion behavior in polyethylene glycol 4000 solid dispersions using a suite of complementary analytical techniques.

Journal of pharmaceutical sciences (2014-05-16)
Dipy M Vasa, Namita Dalal, Jeffrey M Katz, Rahul Roopwani, Akshata Nevrekar, Harshil Patel, Ira S Buckner, Peter L D Wildfong
要旨

Fifteen model drugs were quenched from 3:1 (w/w) mixtures with polyethylene glycol 4000 (PEG4000). The resulting solids were characterized using powder X-ray diffraction (PXRD), analysis of pair distribution function-transformed PXRD data (where appropriate), hot-stage polarized light microscopy, and differential scanning calorimetry (DSC). Drug/polymer dispersion behavior was classified using the data from each technique, independent of the others, and limitations to single-method characterization of PEG-based systems are highlighted. The data from all characterization techniques were collectively used to classify dispersion behavior, which was compared with single-technique characterization. Of the 15 combinations, only six resulted in solids whose dispersion behavior was consistently described using each standalone technique. The other nine were misclassified using at least one standalone technique, mainly because the phase behavior was ambiguously interpreted when only the data from one technique were considered. The data indicated that a suite of complementary techniques provided better classifications of the phase behavior. Of all the quenched solids, only cimetidine was fully dispersed in PEG4000, suggesting that it solidified from a completely miscible mixture of molten drug and polymer that did not phase separate upon cooling. In contrast, ibuprofen and PEG4000 completely recrystallized during preparation, whereas the remaining 13 drugs were partially dispersed in PEG4000 at this composition.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
メラトニン, powder, ≥98% (TLC)
Sigma-Aldrich
インドメタシン, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
イトラコナゾール, ≥98% (HPLC)
Sigma-Aldrich
ニフェジピン, ≥98% (HPLC), powder
Sigma-Aldrich
スルファニルアミド, ≥98%
USP
メラトニン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
インドメタシン, meets USP testing specifications
Sigma-Aldrich
テルフェナジン
Sigma-Aldrich
シメチジン
USP
スルファニルアミド融点標準品, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
グリセオフルビン, from Penicillium griseofulvum, 97.0-102.0%
USP
ニフェジピン, United States Pharmacopeia (USP) Reference Standard
USP
スルファニルアミド, United States Pharmacopeia (USP) Reference Standard
Supelco
トルブタミド, analytical standard
Supelco
インドメタシン, Pharmaceutical Secondary Standard; Certified Reference Material
USP
シメチジン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
スルファニルアミド, puriss. p.a., ≥98% (calc. to the dried substance)
Supelco
スルファニルアミド, Pharmaceutical Secondary Standard; Certified Reference Material
USP
インドメタシン, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
スルファニルアミド, JIS special grade, ≥99.7%
USP
グリセオフルビン, United States Pharmacopeia (USP) Reference Standard
Supelco
スルファニルアミド, VETRANAL®, analytical standard
Supelco
グリセオフルビン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
ニフェジピン, Pharmaceutical Secondary Standard; Certified Reference Material
スルファニルアミド, European Pharmacopoeia (EP) Reference Standard
USP
グリセオフルビン, United States Pharmacopeia (USP) Reference Standard
Supelco
シメチジン, Pharmaceutical Secondary Standard; Certified Reference Material
インドメタシン, European Pharmacopoeia (EP) Reference Standard
Supelco
クロルプロパミド, analytical standard, ≥97%
イトラコナゾール, European Pharmacopoeia (EP) Reference Standard